News & Updates

Skin sensitization and dermatitis appear to be common among workers exposed to high concentrations of epoxy, despite comprehensive skin protection, according to a study.

For the treatment of ureteropelvic junction obstruction (UPJO) in infants and young children, robotic-assisted laparoscopic pyeloplasty (RALP) leads to less trauma and better recovery while reaching comparable efficacy as conventional LP, a recent study has found.

New drug applications approved by US FDA as of 16-30 Sep 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Ligelizumab, a next-generation anti-IgE antibody, is safe and effective in treating patients with H₁-antihistamine (H₁-AH) refractory chronic spontaneous urticaria (CSU), according to two phase III studies presented at EADV 2022.

Adjuvant radiotherapy after surgery helps improve overall survival in older patients with node-positive vulval cancer, as shown in a study.

The risk of adrenal insufficiency is elevated among people exposed to carbon monoxide poisoning (COP), reports a recent study.

Depending on the model being used, recalibration of risk scores using contemporary population-level data may improve risk stratification for statin therapy, suggests a study.